Evidence map›Paper›PMID 41366940›Full record

Observational studyMedicine2025

Osteoporosis in Korean men over 40 years: Prevalence and risk factors.

Seunghee Lee, Su Jeong Yi, Hyunjung Lee

Abstract readObservational Study
In one paragraph

Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seunghee LeeCollege of Nursing, Dankook University, Cheonan, Republic of Korea.
Su Jeong YiCollege of Nursing, Dankook University, Cheonan, Republic of Korea.
Hyunjung LeeCollege of Nursing, Chungnam National University, Daejeon, Republic of Korea.ORCID 0000-0002-8707-8630

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoporosis is increasingly being recognized as a significant health concern in men. However, research on male osteoporosis in Korea remains limited. This study aimed to investigate the prevalence and factors influencing osteoporosis in Korean men aged ≥40 years. Secondary analysis utilized data from the Korean Genome and Epidemiology Study urban cohort (2004-2013), focusing on 58,976 men aged ≥40 years. Variables included sociodemographic characteristics, lifestyle factors, medical history, anthropometric measurements, biometric parameters, and dietary habits. Statistical analyses included analysis of variance, Chi-square tests, and multinomial logistic regression. The prevalence of osteoporosis was 0.6% among the male participants. Risk factors significantly associated with osteoporosis included advanced age (50-59 years: odds ratio (OR) = 1.899; ≥60 years: OR = 3.119), chronic diseases including angina/myocardial infarction (OR = 2.197), fatty liver (OR = 2.297), gallstones/cholecystitis (OR = 2.176), and arthritis (OR = 8.069), poor self-rated health (OR = 3.598), and irregular meal patterns (OR = 2.884). Protective factors included normal or overweight body mass index compared with underweight, moderate total cholesterol levels (140-200 mg/dL: OR = 0.401), and moderate coffee consumption (3-4 times/day: OR = 0.555). Age, chronic diseases, poor self-rated health, and irregular dietary habits significantly increase osteoporosis risk in Korean men. Comprehensive health management strategies focusing on these factors are essential for effective osteoporosis prevention in this population.

Indexed as

OsteoporosisAdultAgedAge FactorsBody Mass IndexHumansLife StyleMaleMiddle AgedPrevalenceRepublic of KoreaRisk FactorsmenosteoporosisprevalenceSouth Korea

Identifiers

PMID41366940
PMCPMC12688839

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.